Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Colorectal Neoplasms 3 Sarcoma 2 Recurrence 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Stage IIIb and IV Non Small Cell Lung Cancer 1 Solid Tumor, Adult 1 Rare Diseases 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplastic Syndromes, Hereditary 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Microsatellite Instability 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Medullary 1 COVID-19 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 101 Etoposide 60 Carboplatin 55 Vincristine 51 Filgrastim 49 Topotecan 44 Temozolomide 44 Melphalan 44 Isotretinoin 44 Doxorubicin 44 Irinotecan 42 Cisplatin 35 3-Iodobenzylguanidine 34 Peripheral Blood Stem Cell Transplantation 31 dinutuximab 30 Granulocyte Colony-Stimulating Factor 30 Radiotherapy 29 sargramostim 28 Granulocyte-Macrophage Colony-Stimulating Factor 25 Busulfan 22 Magnetic Resonance Spectroscopy 19 aldesleukin 18 Thiotepa 18 fludarabine 17 Interleukin-2 17 humanized 3F8 anti-GD2 monoclonal antibody 16 etoposide phosphate 16 naxitamab 15 Ifosfamide 15 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × High-Throughput Nucleotide Sequencing × Clear all

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡